Hearing Information
Amendment Deadline
Monday, June 11, 2018 - 3:00pm H-312, the Capitol View Announcement »
Meeting Information
Tuesday, June 12, 2018 - 5:00pm H-313, the Capitol View Announcement »
H.R. 2851 - Stop the Importation and Trafficking of Synthetic Analogues Act of 2017
Video
Bill Text
Hearing Documents
Rule Information
COMMITTEE ACTION:
REPORTED BY RECORD VOTE of 7-4 on Tuesday, June 12, 2018.
FLOOR ACTION ON H. RES. 934:
Agreed to by record vote of 233-175, after agreeing to the previous questions by record vote of 230-183 on Wednesday, June 13, 2018.
MANAGERS: Buck/Polis
1. Structured rule for H.R. 2851.
2. Provides one hour of general debate equally divided and controlled by the chair and ranking minority member of the Committee on the Judiciary.
3. Waives all points of order against consideration of the bill.
4. Makes in order as original text for the purpose of amendment an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-74 and provides that it shall be considered as read.
5. Waives all points of order against that amendment in the nature of a substitute.
6. Makes in order only those further amendments printed in part A of the Rules Committee report. Each such amendment may be offered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, shall not be subject to amendment, and shall not be subject to a demand for division of the question.
7. Waives all points of order against the amendments printed in part A of the report.
8. Provides one motion to recommit with or without instructions.
9. Structured rule for H.R. 5735.
10. Provides one hour of general debate equally divided and controlled by the chair and ranking minority member of the Committee on Financial Services.
11. Waives all points of order against consideration of the bill.
12. Makes in order as original text for the purpose of amendment an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-73 and provides that it shall be considered as read.
13. Waives all points of order against that amendment in the nature of a substitute.
14. Makes in order only those further amendments printed in part B of the Rules Committee report. Each such amendment may be offered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, shall not be subject to amendment, and shall not be subject to a demand for division of the question.
15. Waives all points of order against the amendments printed in part B of the report.
16. Provides one motion to recommit with or without instructions.
17. Closed rule for H.R. 5788.
18. Provides one hour of debate equally divided and controlled by the chair and ranking minority member of the Committee on Ways and Means.
19. Waives all points of order against consideration of the bill.
20. Provides that the amendment printed in part C of the Rules Committee report, modified by the amendment printed in part D of the report, shall be considered as adopted and the bill, as amended, shall be considered as read.
21. Waives all points of order against provisions in the bill, as amended.
22. Provides one motion to recommit with or without instructions.
Amendments (click headers to sort)
| # | Version # | Sponsor(s) | Party | Summary | Status |
|---|---|---|---|---|---|
| 14 | Version 1 | Adams (NC) | Democrat | Late Requires the Attorney General to consult the American Chemical Society and International Union of Pure and Applied Chemistry when making determinations of drug equivalencies. | Submitted |
| 15 | Version 2 | Adams (NC) | Democrat | Late Revised Requires the Attorney General to consider the conclusions of a Section 201(b) analysis conducted by the Secretary of HHS in any scheduling determination. | Submitted |
| 11 | Version 1 | Biggs (AZ) | Republican | Removes the AG’s authority to permanently schedule a substance on Schedule A; requires an imminent hazard to public safety for scheduling temporarily; and limits the temporary scheduling authority to 2 years instead of 5. | Submitted |
| 8 | Version 1 | Connolly (VA) | Democrat | Restores the Drug Enforcement Agency’s authority to suspend a pharmaceutical distributor’s license to stop suspicious shipments of prescription drugs. | Submitted |
| 1 | Version 2 | Griffith (VA), Raskin (MD), Jackson Lee (TX) | Bi-Partisan | Revised Incorporates an inter-agency agreement transmitted to Congress by the Office of National Drug Control Policy (ONDCP), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ). Specifically, the amendment clarifies when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A and prevents the Attorney General from permanently scheduling that drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse. The amendment also clarifies under what circumstances an applicant for a schedule A registration may continue to conduct research with such schedule A substance while their application is pending, among their research accommodations. | Made In Order |
| 4 | Version 1 | Jackson Lee (TX) | Democrat | Strikes sentencing commission provision. | Made In Order |
| 5 | Version 1 | Jackson Lee (TX) | Democrat | Criminalizes managers and leaders of criminal activity | Submitted |
| 9 | Version 1 | Jackson Lee (TX) | Democrat | Ensures penalties for schedule A controlled substance may not be ordered to run consecutively. | Submitted |
| 16 | Version 2 | Jackson Lee (TX) | Democrat | Late Revised Strikes mandatory minimum terms of supervised release | Submitted |
| 12 | Version 1 | Keating (MA) | Democrat | Late Repeals Public Law 114–145, which compromised the ability of the DEA to swiftly act to combat unsafe opioid distribution. | Submitted |
| 6 | Version 2 | Maloney, Sean (NY) | Democrat | Revised Requires the Drug Enforcement Administration to make available a report on controlled substance analogues sold by means of the internet. | Made In Order |
| 2 | Version 1 | Norcross (NJ) | Democrat | Requires 30% of funds collected from fines in this bill are authorized to go towards the Bureau of Justice Assistance’s Residential Substance Abuse Treatment for State Prisoners Program. | Submitted |
| 3 | Version 1 | Norcross (NJ) | Democrat | Requires 30% of funds collected from fines in this bill are authorized to go towards substance use disorder treatment programs within the federal Bureau of Prisons. | Submitted |
| 10 | Version 1 | Pocan (WI), Gosar (AZ), Polis (CO) | Bi-Partisan | Prevents the Secretary from placing a natural botanical substance under new Scheduling authority, and would require Secretary to use existing scheduling proceedings under the Controlled Substances Act, if supported by existing medical and scientific facts. | Submitted |
| 7 | Version 1 | Polis (CO), Correa (CA) | Democrat | Requires the VA to study medicinal marijuana as an alternative treatment option to prescription opioids. | Submitted |
| 13 | Version 1 | Thornberry (TX) | Republican | Late Specifies the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers. | Made In Order |
Committee Votes
Rules Committee Record Vote No. 233
Motion by Mr. Polis to make in order and provide the appropriate waivers to amendment #10, offered by Rep. Pocan (WI) and Rep. Gosar (AZ) and Rep. Polis (CO), which prevents the Secretary from placing a natural botanical substance under new Scheduling authority, and would require Secretary to use existing scheduling proceedings under the Controlled Substances Act, if supported by existing medical and scientific facts. Defeated: 4–6
Majority Member
Vote
Mr. Cole
No Vote
Mr. Woodall
Nay
Mr. Burgess
Nay
Mr. Collins
Nay
Mr. Byrne
No Vote
Mr. Newhouse
Nay
Mr. Buck
No Vote
Ms. Cheney
Nay
Mr. Sessions, Chairman
Nay
Minority Member
Vote
Mr. McGovern
Yea
Mr. Hastings
Yea
Mr. Polis
Yea
Mrs. Torres
Yea
Rules Committee Record Vote No. 234
Motion by Mr. Polis to make in order and provide the appropriate waivers to amendment #7, offered by Rep. Polis (CO) and Rep. Correa (CA), which requires the VA to study medicinal marijuana as an alternative treatment option to prescription opioids. Defeated: 4–7
Majority Member
Vote
Mr. Cole
No Vote
Mr. Woodall
Nay
Mr. Burgess
Nay
Mr. Collins
Nay
Mr. Byrne
No Vote
Mr. Newhouse
Nay
Mr. Buck
Nay
Ms. Cheney
Nay
Mr. Sessions, Chairman
Nay
Minority Member
Vote
Mr. McGovern
Yea
Mr. Hastings
Yea
Mr. Polis
Yea
Mrs. Torres
Yea
Rules Committee Record Vote No. 235
Motion by Mr. Woodall to report the rule. Adopted: 7-4
Majority Member
Vote
Mr. Cole
No Vote
Mr. Woodall
Yea
Mr. Burgess
Yea
Mr. Collins
Yea
Mr. Byrne
No Vote
Mr. Newhouse
Yea
Mr. Buck
Yea
Ms. Cheney
Yea
Mr. Sessions, Chairman
Yea
Minority Member
Vote
Mr. McGovern
Nay
Mr. Hastings
Nay
Mr. Polis
Nay
Mrs. Torres
Nay